SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001818382-22-000030
Filing Date
2022-04-29
Accepted
2022-04-29 06:44:37
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A huma-2022defa14a.htm DEFA14A 9430
2 humanoticepg1a.jpg GRAPHIC 91874
3 humanoticepg2a.jpg GRAPHIC 63132
  Complete submission text file 0001818382-22-000030.txt   213377
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39532 | Film No.: 22869985
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences